“Mosaic” HIV Vaccine Triggers Immune Response In People In Clinical Trial.

AFP (7/6, Roux) reported that Imbokodo (HVTN705), an HIV vaccine candidate, has been shown to be safe in people, and “triggered an immune response in humans” as well as monkeys in a clinical trial. The results of the trial were published in The Lancet. T...